MiMedx Announces $25 Million Patent License Agreement
MiMedx says it entered a license agreement with a wound care competitor, resolving allegations of patent infringement.
Story updates
08:04:28 PM UTC
SquawkNews
MiMedx Group, Inc. announced a $25M patent license agreement with a wound care competitor, resolving infringement allegations and providing recurring cash over several years.Material DetailsContext by AI AnalystThis is a mid-cycle confirmation of MIMEDX’s IP monetization strategy, adding validated…
08:10:55 PM UTC
SquawkNews
Reports Continued Double-Digit Year-Over-Year Volume Growth for Surgical FranchiseDelivers Wound Care Center Volume Growth Both Sequentially and Year-Over-YearObtained Favorable Federal Court Ruling in AXIOFILL® Regulatory Classification Matter During QuarterToday Announced Patent License Agreement…
MARIETTA, Ga., Oct. 28, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. NASDAQ:MDXG (“MIMEDX” or the “Company”) today announced that it has entered into a license agreement with a wound care competitor that resolves allegations of infringement of MIMEDX’s patents.Under the terms of the agreement:“This…